ELBIT IMAGING LTD
Elbit Imaging develops and markets therapeutic medical systems for non-invasive treatments on the human body. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging. It also produces stem cell-based products for bone marrow transplantation in patients with certain diseases. Additionally, the company sells plots and villas in India. Elbit Imaging was formerly known as Elbit Medical Imaging Ltd. and changed its name in 2007. The company was incorporated in 1996 and is headquartered in Israel.
Overview
Strengths
- Valued below its Real Estate - Development peers: P/FCF 4.4x vs. a median of 11.8x.
- Skin in the game: insiders own 55% of the shares, aligning management with shareholders.
- Cheaper than its own history: P/FCF 4.4x vs. a historical average of 85.1x.
Weaknesses
- No sign of a competitive advantage: return on invested capital (latest 2.1%) has been below its cost of capital of 4.2% in each of the last 6 years.
- Operating profit does not cover interest expense.
- Our discounted cash flow model finds no value to support the current price: operating profit does not cover interest expense.
- Shareholder dilution: the share count has grown by 13.1% a year over the last three years.
- Currently loss-making: the latest fiscal year closed with a net loss.
- Unreliable cash generation: free cash flow was negative in 5 of the last 6 years.
Key Financial Data